Drug Discovery Technology Trends and Forecast
The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets. The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030 with a CAGR of 9.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.A more than 150-page report is developed to help in your business decisions.
Drug Discovery Technology by Segment
The study includes a forecast for the global drug discovery technology by technology, application, end use industry, tech, and region.Drug Discovery Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- High Throughput Screening
- Genomics
- Biochips
- Pharmacogenomics
- Bioanalytical Instruments
- Bioinformatics
- Nanotechnology
- Others
Drug Discovery Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Cardiovascular Diseases
- Parkinson's
- Alzheimer's
- Others
Drug Discovery Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Biotech Companies
- Research Institutes
Drug Discovery Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Drug Discovery Technology Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery technology companies profiled in this report include:- Abbott Laboratories
- Affymetrix
- Agilent Technologies
- Albany Molecular Research
- ArQule
- AstraZeneca
- Bio-Rad Laboratories
- Caliper Life Sciences
- Celera
- Charles River Laboratories
Drug Discovery Technology Market Insights
The publisher forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.Within this market, biopharmaceutical company will remain the largest segment because it comprises a large number of international companies that invest heavily in biopharmaceutical medication research and development.
North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.
Features of the Global Drug Discovery Technology Market
- Market Size Estimates: Drug discovery technology market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Drug discovery technology market size by technology, application, end use industry, tech, and region in terms of value ($B).
- Regional Analysis: Drug discovery technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different technology, application, end use industry, tech, and regions for the drug discovery technology market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discovery technology market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the drug discovery technology market size?Answer: The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030.
Q2. What is the growth forecast for drug discovery technology market?
Answer: The global drug discovery technology market is expected to grow with a CAGR of 9.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the drug discovery technology market?
Answer: The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.
Q4. What are the major segments for drug discovery technology market?
Answer: The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets.
Q5. Who are the key drug discovery technology market companies?
Answer: Some of the key drug discovery technology companies are as follows:
- Abbott Laboratories
- Affymetrix
- Agilent Technologies
- Albany Molecular Research
- ArQule
- AstraZeneca
- Bio-Rad Laboratories
- Caliper Life Sciences
- Celera
- Charles River Laboratories
Answer: The publisher forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.
Q7. In drug discovery technology market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the drug discovery technology market by technology (high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology, and others), application (cardiovascular diseases, Parkinson's, Alzheimer's, and others), end use industry (pharmaceutical companies, biopharmaceutical companies, biotech companies, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Drug Discovery Technology Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Abbott Laboratories
- Affymetrix
- Agilent Technologies
- Albany Molecular Research
- ArQule
- AstraZeneca
- Bio-Rad Laboratories
- Caliper Life Sciences
- Celera
- Charles River Laboratories
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
